Second primary cancer risk - The impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Coyte, Aishah ^a   Morrison, David S ^a   McLoone, Philip ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cancer registry; Relative risk; Scotland; Second primary cancer; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREVALENCE; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; UNITED KINGDOM; VERY ELDERLY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVOR;

FEMALE; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SCOTLAND; SURVIVORS;

EID: 84899946242     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-272     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Moller H. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 2009, 101:541-547. 10.1038/sj.bjc.6605148, 2720244, 19568236.
3. Forman D, Stockton D, Moller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer prevalence in the UK: results from the EUROPREVAL study. Ann Oncol 2003, 14:648-654. http://dx.doi.org/10.1093/annonc/mdg169, 10.1093/annonc/mdg169, 12649115.
4. Rutten LJ, Arora NK, Bakos AD, Aziz N, Rowland J. Information needs and sources of information among cancer patients: a systematic review of research (1980-2003). Patient Educ Couns 2005, 57:250-261. 10.1016/j.pec.2004.06.006, 15893206.
5. Mehnert A, Koch U, Sundermann C, Dinkel A. Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol 2013, 52:1102-1109. http://dx.doi.org/10.3109/0284186X.2013.765063, 10.3109/0284186X.2013.765063, 23384721.
6. Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. NIH Publ. No. 05-5302 2006, Bethesda, MD: National Cancer Institute.
7. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003, 56:1038-1045. http://dx.doi.org/10.1016/S0360-3016(03)00203-7, 10.1016/S0360-3016(03)00203-7, 12829139.
8. Soerjomataram I, Louwman WJ, van der Sangen MJ, Roumen RM, Coebergh JW. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer 2006, 95:393-397. http://dx.doi.org/10.1038/sj.bjc.6603231, 10.1038/sj.bjc.6603231, 2360642, 16804522.
9. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:855-861.
10. Levi F, Randimbison L, Blanc-Moya R, Maspoli-Conconi M, Rosato V, Bosetti C, La Vecchia C. High constant incidence of second primary colorectal cancer. Int J Cancer 2013, 132:1679-1682. 10.1002/ijc.27780, 22903312.
11. Liu L, Lemmens VE, De Hingh IH, de Vries E, Roukema JA, van Leerdam ME, Coebergh JW, Soerjomataram I. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer. Dis Colon Rectum 2013, 56:158-168. 10.1097/DCR.0b013e318279eb30, 23303143.
12. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA. Increased risk of second lung cancer in hodgkin's lymphoma survivors: a meta-analysis. Lung 2013, 191:117-134. 10.1007/s00408-012-9418-4, 23053567.
13. Jegu J, Binder-Foucard F, Borel C, Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 2013, 49:9-14. 10.1016/j.oraloncology.2012.06.018, 22840787.
14. Scholes S, Bajekal M, Love H, Hawkins N, Raine R, O'Flaherty M, Capewell S. Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC Public Health 2012, 12:129. http://dx.doi.org/10.1186/1471-2458-12-129, 10.1186/1471-2458-12-129, 3342910, 22333887.
15. Hotchkiss JW, Davies C, Gray L, Bromley C, Capewell S, Leyland AH. Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open 2011, 1(1):e000176. http://dx.doi.org/10.1136/bmjopen-2011-000176, 3191578, 22021783.
16. Howel D. Waist circumference and abdominal obesity among older adults: patterns, prevalence and trends. PLoS One 2012, 7:e48528. http://dx.doi.org/10.1371/journal.pone.0048528, 10.1371/journal.pone.0048528, 3485367, 23119047.
17. The NHS cancer screening programmes website. [http://www.cancerscreening.nhs.uk/] Accessed: 19th March 2014.
18. Moser K, Sellars S, Wheaton M, Cooke J, Duncan A, Maxwell A, Michell M, Wilson M, Beral V, Peto R, Richards M, Patnick J. Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen 2011, 18:96-102. http://dx.doi.org/10.1258/jms.2011.011065, 10.1258/jms.2011.011065, 21852703.
19. Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology 2013, 266:388-405. 10.1148/radiol.12110853, 23220901.
20. Chopra A, Ford A, De Noronha R, Matthews S. Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer. Br J Radiol 2012, 85:e229-e237. http://dx.doi.org/10.1259/bjr/60606623, 10.1259/bjr/60606623, 3474053, 22745208.
21. Adamo MB, Johnson CH, Ruhl JL, Dickie LA. 2012 SEER Program Coding and Staging Manual. NIH Publication number 12-5581 2012, Bethesda, MD: National Cancer Institute.
22. IARC/ENCR/IACR Working Group International rules for multiple primary cancers. Asian Pacific J Cancer Prev 2005, 6:104-106. IARC/ENCR/IACR Working Group.
23. International Agency for Research on Cancer International Rules for Multiple Primary Cancers (ICD-O Third Edition). Internal Report No. 2004/02 2004, Lyon: IARC, International Agency for Research on Cancer.
24. Brewster D, Crichton J, Muir C. How accurate are Scottish cancer registration data?. Br J Cancer 1994, 70:954-959. 10.1038/bjc.1994.428, 2033548, 7947104.
25. Brewster D, Muir C, Crichton J. Registration of lung cancer in Scotland: an assessment of data accuracy based on review of medical records. Cancer Causes Control 1995, 6:303-310. 10.1007/BF00051405, 7548717.
26. Brewster D, Muir C, Crichton J. Registration of colorectal cancer in Scotland: an assessment of data accuracy based on review of medical records. Public Health 1995, 109:285-292. 10.1016/S0033-3506(95)80206-1, 7667493.
27. Ferlay J, Burkhard C, Whelan S, Parkin DM. Check and conversion programs for cancer registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42 2005, Lyon: IARC, Available from http://www.iacr.com.fr/TechRep42-MPrules.pdf. Accessed online 19th March 2014.
28. Johnson CH, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards BK. The 2007 Multiple Primary and Histology Coding Rules 2007, Bethesda, MD: National Cancer Institute.
29. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer 2001, 93:155-161. 10.1002/ijc.1317, 11410860.
30. Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer 2011, 11:83. http://dx.doi.org/10.1186/1471-2407-11-83, 10.1186/1471-2407-11-83, 3052198, 21342533.
31. Crocetti E, Buiatti E, Falini P. Multiple primary cancer incidence in Italy. Eur J Cancer 2001, 37:2449-2456. 10.1016/S0959-8049(01)00314-8, 11720842.
32. Atienza JA, Dasanu CA. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin 2012, 28:1899-1909. 10.1185/03007995.2012.746218, 23121148.
33. Kellen E, Kiyohara H. Multiple primary cancer (MPC) associated with bladder cancer: an analysis of the clinical and autopsy cases in Japan. Jpn J Clin Oncol 1985, 15(S1):201-210.
34. Fabbri C, Ravaioli A, Ravaioli A, Bucchi L, Balducci C, Canuti D, Desiderio F, Foca F, Panzini I, Falcini F. Risk of cancer of the prostate and of the kidney parenchyma following bladder cancer. Tumori 2007, 93:124-128.
35. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P. Risk of second cancer among women with breast cancer. Int J Cancer 2006, 118:2285-2292. 10.1002/ijc.21651, 16342146.
36. Yang GB, Barnholtz-Sloan JS, Chen Y, Bordeaux JS. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Arch Dermatol 2011, 147:1395-1402. http://dx.doi.org/10.1001/archdermatol.2011.1133, 10.1001/archdermatol.2011.1133, 22184761.
37. Schmid-Wendtner MH, Baumert J, Wendtner CM, Plewig G, Volkenandt M. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001, 145:981-985. 10.1046/j.1365-2133.2001.04507.x, 11899153.
38. Thellenberg C, Malmer B, Tavelin B, Gronberg H. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003, 169:1345-1348. 10.1097/01.ju.0000056706.88960.7c, 12629357.
39. Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001, 10:793-798.
40. Hemminki K, Aaltonen L, Li X. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 2003, 97:2432-2439. 10.1002/cncr.11372, 12733142.
41. Liu L, de Vries E, Louwman M, Aben K, Janssen-Heijnen M, Brink M, Coebergh JW, Soerjomataram I. Prevalence of multiple malignancies in the Netherlands in 2007. Int J Cancer 2011, 128:1659-1667. http://dx.doi.org/10.1002/ijc.25480, 10.1002/ijc.25480, 20503267.
42. Parkin DM. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011, 105:S2-S5. http://dx.doi.org/10.1038/bjc.2011.474, 3252063, 22158314.